PHARMACOECONOMIC ANALYSIS OF RESLIZUMAB USE IN SEVERE ATOPIC ASTHMA WITH EOSINOPHILIA

被引：0
|
作者：
Kolbin, A. [1 ]
Gomon, J. [2 ]
Balykina, Y. [3 ]
Proskurin, M. [4 ]
机构：
[1] First Pavlov State Med Univ St Petersburg, St Petersburg, Russia
[2] Pavlov Med Univ, St Petersburg, Russia
[3] St Petersburg State Univ, St Petersburg, Spe, Russia
[4] St Petersburg State Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS12
引用
收藏
页码：S874 / S874
页数：1
相关论文
共 50 条
  • [41] Implementation of the FEOS score in patients with severe eosinophilic asthma treated with Reslizumab.
    Liendo Martinez, Katiuska Herminia
    Correa Gutierrez, Crishian Alonso
    Briones Alvarado, Stephany Ivonne
    Mor Martinez, Manuel
    Puente Maestu, Luis
    Garcia De Pedro, Julia
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [42] Impact Of Reslizumab On Healthcare Resource Utilization In Adult Patients With Severe Eosinophilic Asthma
    Wechsler, M. E.
    Korn, S.
    Sun, S. X.
    Garin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [43] Reslizumab improves FVC and FEF25%-75% in severe eosinophilic asthma: results from a pooled analysis
    Carr, Warner W.
    McDonald, Mirna
    Meizlik, Paige
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB195 - AB195
  • [44] Effectiveness of Reslizumab in Severe Asthma treatment; a real-world experience.
    Ibrahim, H.
    O'Sullivan, R.
    Casey, D.
    Murphy, J.
    Plant, B. J.
    Murphy, D. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S270 - S271
  • [45] Analysis of Lap Protein in Monocytes of Patients with Severe Atopic Bronchial Asthma
    Ibragimov, B.
    Skibo, Y.
    Abramova, Z.
    Reshetnikova, I.
    Tikhomirova, M.
    Abramov, S.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52
  • [46] GATA3 Polymorphisms Are Predictors Of Steroid Use And Atopic Asthma In The Severe Asthma Research Program
    Slager, R. E.
    Pascual, R. M.
    Moore, W. C.
    Hawkins, G. A.
    Peters, S. P.
    Meyers, D.
    Bleecker, E. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [47] Children's atopic dermatitis: Pharmacoeconomic cost analysis
    Derkach, V
    Prosekova, E
    VALUE IN HEALTH, 2003, 6 (06) : 785 - 785
  • [48] Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
    de Llano, Luis A. Perez
    Cosio, Borja G.
    Astiarraga, Ignacio Lobato
    Campos, Gregorio Soto
    Alonso, Miguel Angel Tejedor
    Malanda, Nuria Marina
    Galo, Alicia Padilla
    Landa, Isabel Urrutia
    de la Rosa, Francisco J. Michel
    Garcia-Moguel, Ismael
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 79 - 88
  • [49] Real-World Evidence of Improved Patient Outcomes with Reslizumab in Adults with Severe Eosinophilic Asthma: A Subgroup Analysis of Patients Receiving Reslizumab for More Than 12 Months
    Wechsler, M.
    Peters, S. P.
    Chipps, B. E.
    Hill, T.
    Ariely, R.
    DePietro, M.
    Driessen, M.
    Terasawa, E.
    Thomason, D.
    Panettieri, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [50] Increased TGF-β2 in severe asthma with eosinophilia
    Balzar, S
    Chu, HW
    Silkoff, P
    Cundall, M
    Trudeau, JB
    Strand, M
    Wenzel, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (01) : 110 - 117
12345